Scientists reprogram Patients' own cells to fight advanced liver cancer
Disease control
Recruiting now
This early-stage trial is testing a new personalized treatment called ECT204 T-cell therapy for adults with advanced liver cancer (hepatocellular carcinoma) that has not responded to at least two other treatments. Doctors collect a patient's own immune cells, genetically modify t…
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC